Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Toxicology

• Publication date

  2005-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.TOX.2005.06.023PMID 16085349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Poly(ADP-Ribose) Polymerase-1 Promotes Microglial Activation, Proliferation, and Matrix Metalloproteinase-9-Mediated Neuron Death1

  2005cited by this paper
• Evodiamine Abolishes Constitutive and Inducible NF-κB Activation by Inhibiting IκBα Kinase Activation, Thereby Suppressing NF-κB-regulated Antiapoptotic and Metastatic Gene Expression, Up-regulating Apoptosis, and Inhibiting Invasion*

  2005cited by this paper
• Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.

  2005cited by this paper
• Epigallocatechin-3-gallate causes the p21/WAF1-mediated G1-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-α-induced vascular smooth muscle cells

  2005cited by this paper
• Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion.

  2005cited by this paper
• Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling.

  2004cited by this paper
• Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor‐κB signaling

  2004cited by this paper
• NF-kappaB functions as a tumour promoter in inflammation-associated cancer.

  2004cited by this paper
• Regulation of Kinase Cascades and Transcription Factors by a Poly(ADP-Ribose) Polymerase-1 Inhibitor, 4-Hydroxyquinazoline, in Lipopolysaccharide-Induced Inflammation in Mice

  2004cited by this paper
• The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals

  2004cited by this paper
• Critical Role of the Automodification of Poly(ADP-ribose) Polymerase-1 in Nuclear Factor-κB-dependent Gene Expression in Primary Cultured Mouse Glial Cells*

  2004cited by this paper
• NF-κB functions as a tumour promoter in inflammation-associated cancer

  2004cited by this paper
• Effect of poly(ADP-ribose) polymerase inhibitors on oxidative stress evoked hydroxyl radical level and macromolecules oxidation in cell free system of rat brain cortex.

  2004cited by this paper
• Neurological diseases: Mechanisms, challenges and opportunities in stroke

  2003cited by this paper
• Poly(ADP‐Ribose) Polymerase‐1 in Acute Neuronal Death and Inflammation

  2003cited by this paper
• Transcriptional Coactivation of Nuclear Factor-κB-dependent Gene Expression by p300 Is Regulated by Poly(ADP)-ribose Polymerase-1*

  2003cited by this paper
• Poly(ADP‐ribose) polymerase‐1 activity promotes NF‐κB‐driven transcription and microglial activation: implication for neurodegenerative disorders

  2003cited by this paper
• Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection.

  2003cited by this paper
• Matrix metalloproteinases in neuroinflammation

  2002cited by this paper
• Matrix Metalloproteinase Expression After Human Cardioembolic Stroke: Temporal Profile and Relation to Neurological Impairment

  2001cited by this paper
• Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1

  2001cited by this paper
• Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia

  1999cited by this paper
• Matrix Metalloproteinases in Cerebrovascular Disease

  1998cited by this paper
• Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat.

  1998cited by this paper
• Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.

  1998cited by this paper
• Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.

  1998cited by this paper
• Poly(ADP‐Ribose) Synthetase Activation: An Early Indicator of Neurotoxic DNA Damage

  1995cited by this paper
• Polymorphonuclear Leukocyte Behavior in a Nonhuman Primate Focal Ischemia Model

  1994cited by this paper
• Correlation Between Myeloperoxidase‐Quantified Neutrophil Accumulation and Ischemic Brain Injury in the Rat: Effects of Neutrophil Depletion

  1994cited by this paper
• Reperfusion Increases Neutrophils and Leukotriene B4 Receptor Binding in Rat Focal Ischemia

  1992cited by this paper
• Subcellular localization and release of human neutrophil gelatinase, confirming the existence of separate gelatinase-containing granules.

  1992cited by this paper
• Metalloproteinases and their inhibitors in matrix remodeling.

  1990cited by this paper
• Striking similarity of the distribution patterns of the poly(ADP-ribose) polymerase and DNA polymerase beta among various mouse organs.

  1990cited by this paper
• Collagenase-induced intracerebral hemorrhage in rats.

  1990cited by this paper
• Poly(ADP-ribose) in the cellular response to DNA damage.

  1985cited by this paper
• Secretion of collagenolytic enzymes by human polymorphonuclear leukocytes.

  1984cited by this paper
• Immunohistochemical demonstration of poly(adenosine diphosphate-ribose) in nuclei of various rat tissues.

  1980cited by this paper

• Clarifying the mechanism of astaxanthin in the treatment of inflammation in ischemic stroke using integrated network analysis.

  2025cites this paper
• The Involvement of Sting in Exacerbating Acute Lung Injury in Sepsis via the PARP-1/NLRP3 Signaling Pathway.

  2024cites this paper
• Vascular oxidative stress causes neutrophil arrest in brain capillaries, leading to decreased cerebral blood flow and contributing to memory impairment in a mouse model of Alzheimer’s disease

  2023cites this paper
• Radiation-induced neuroinflammation: a potential protective role for poly(ADP-ribose) polymerase inhibitors?

  2022cites this paper
• Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke

  2022cites this paper
• Involvement of poly(ADP-ribose)ylation (PARylation) in the regulation of antioxidant defense system in Arabidopsis thaliana under salt stress

  2022cites this paper
• Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6/2 Mouse Model of Huntington’s Disease

  2020cites this paper
• HDAC Inhibitors Induce BDNF Expression and Promote Neurite Outgrowth in Human Neural Progenitor Cells-Derived Neurons

  2019cites this paper
• Anti-apoptotic effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, against multiple organ damage induced by gamma irradiation in rats

  2018cites this paper
• Early Activation of Phosphatidylinositol 3-Kinase after Ischemic Stroke Reduces Infarct Volume and Improves Long-Term Behavior

  2017cites this paper
• Therapeutic Targeting of Poly(ADP‐Ribose) Polymerase‐1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities

  2017cites this paper
• Poly(ADP-ribose)polymerase-1 hyperactivation in neurodegenerative diseases: The death knell tolls for neurons.

  2017cites this paper
• Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling

  2017cites this paper
• Oxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic Stroke

  2016cites this paper
• Nobiletin promotes antioxidant and anti-inflammatory responses and elicits protection against ischemic stroke in vivo.

  2016cites this paper
• Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.

  2015cites this paper
• PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease

  2015cites this paper
• 3‐aminobenzamide, a poly (ADP ribose) polymerase inhibitor, enhances wound healing in whole body gamma irradiated model

  2015cites this paper
• 3-AMINOBENZAMIDE, A POLY (ADP-RIBOSE) POLYMERASE INHIBITOR, RESTORES BIOENERGETICS BUT FAILS TO ALLEVIATE EXCITOTOXICITY AND MOTOR FUNCTIONS IN 3-NITROPROPIONIC ACID INTOXICATED MICE

  2015cites this paper
• Strategies for Pharmacological Organoprotection during Extracorporeal Circulation Targeting Ischemia-Reperfusion Injury

  2015cites this paper
• Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca(2+) Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?

  2015cites this paper
• 3-aminobenzamide, one of poly(ADP-ribose)polymerase-1 inhibitors, rescuesapoptosisin rat models of spinal cord injury.

  2015cites this paper
• Activation of the phosphatidylinositol 3‐kinase pathway plays important roles in reduction of cerebral infarction by cilnidipine

  2015cites this paper
• Molecular Biology of Brain Injury: 2012

  2014cites this paper
• Beneficial effects of edaravone on the expression of serum matrix metalloproteinase-9 after cerebral hemorrhage.

  2014cites this paper
• Neuroprotective Mechanisms of Taurine against Ischemic Stroke

  2013cites this paper
• Synthetic lethality and functional study of DNA repair defects in ERCC1-deficient non-small-cell lung cancer

  2013cites this paper
• Adoptive regulatory T‐cell therapy protects against cerebral ischemia

  2013cites this paper
• Combined therapy with PJ34, a poly(ADP‐ribose)polymerase inhibitor, reduces tissue plasminogen activator‐induced hemorrhagic transformations in cerebral ischemia in mice

  2013cites this paper
• Expression and activation of matrix metalloproteinase-9 and NADPH oxidase in tissues and plasma of experimental autoimmune encephalomyelitis in mice.

  2012cites this paper
• Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB

  2012cites this paper
• A Lipoxin A4 Analog Ameliorates Blood–Brain Barrier Dysfunction and Reduces MMP-9 Expression in a Rat Model of Focal Cerebral Ischemia–Reperfusion Injury

  2012cites this paper
• Role of poly(ADP‐ribose) polymerases in the regulation of inflammatory processes

  2012cites this paper
• In vitro screening of NADPH oxidase inhibitors and in vivo effects of L-leucinethiol on experimental autoimmune encephalomyelitis-induced mice.

  2012cites this paper
• Blood-brain barrier changes in hemorrhagic shock and after cerebral ischemia-reperfusion . Possible protective mechanisms

  2011cites this paper
• Suppression of matrix metalloproteinase-9 expression in undifferentiated, non-apoptotic keratinocytes is abrogated by the cleavage of poly(ADP-ribose) polymerase-1

  2011cites this paper
• Microbleeds and free active MMP‐9 are independent risk factors for neurological deterioration in acute lacunar stroke

  2011cites this paper
• Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia.

  2011cites this paper
• Calcium signal-initiated early activation of NF-κB in neurons is a neuroprotective event in response to kainic acid-induced excitotoxicity

  2010cites this paper
• Effect of Acute Poly(ADP-Ribose) Polymerase Inhibition by 3-AB on Blood–Brain Barrier Permeability and Edema Formation after Focal Traumatic Brain Injury in Rats

  2010cites this paper
• Pyruvate-enriched cardioplegia suppresses cardiopulmonary bypass-induced myocardial inflammation.

  2010cites this paper
• Genetic ablation of PARP-1 protects against oxazolone-induced contact hypersensitivity by modulating oxidative stress.

  2010cites this paper
• Sonographic monitoring of mass effect in stroke patients treated with hypothermia. Correlation with intracranial pressure and matrix metalloproteinase 2 and 9 expression

  2010cites this paper
• Poly(ADP‐ribose)polymerase inhibitor can attenuate the neuronal death after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced neurotoxicity in mice

  2009cites this paper
• Erythropoietin Increases the Motility of Human Bone Marrow-Multipotent Stromal Cells (hBM-MSCs) and Enhances the Production of Neurotrophic Factors From hBM-MSCs

  2009cites this paper
• Poly(ADP-Ribose) Polymerase Inhibition Down-Regulates Expression of Metastasis-Related Genes in CT26 Colon Carcinoma Cells

  2009cites this paper
• Post‐ischemic brain damage: targeting PARP‐1 within the ischemic neurovascular units as a realistic avenue to stroke treatment

  2009cites this paper
• Poly ( ADP-Ribose ) Polymerase Inhibition Down-Regulates Expression of Metastasis-Related Genes in CT 26 Colon Carcinoma Cells

  2009cites this paper
• Mechanisms underlying hypoxic ischemic injury to the developing brain : the significance of matrix metalloproteinase 2 and 9.

  2009cites this paper
• Plasma and Brain Matrix Metalloproteinase-9 After Acute Focal Cerebral Ischemia in Rats

  2009cites this paper
• Poly(ADP-Ribosylation): Beneficial Effects of Its Inhibition

  2009cites this paper
• Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage.

  2008cites this paper
• Inhibition of GSK-3 reduces infarct volume and improves neurobehavioral functions.

  2008cites this paper
• Pyruvate enhances neurological recovery following cardiopulmonary arrest and resuscitation.

  2008cites this paper
• Multiphasic roles for matrix metalloproteinases after stroke.

  2008cites this paper
• Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.

  2008cites this paper
• Molecular Mechanisms of Apoptosis in Cerebral Ischemia: Multiple Neuroprotective Opportunities

  2008cites this paper
• Poly(ADP-ribose) polymerase inhibitor is neuroprotective in epileptic rat via apoptosis-inducing factor and Akt signaling

  2007cites this paper
• The Relationship of Matrix Metalloproteinase-9 and Microbleeds on $T_2^{\ast}-Weighted$ Gradient-Echo MRI in Acute Lacunar Infarction

  2006cites this paper
• An improved post-operative care protocol allows detection of long-term functional deficits following MCAo surgery in rats.

  2006cites this paper
• The Role of Matrix Metalloproteinase 9 in Early Neurological Worsening of Acute Lacunar Infarction

  2006cites this paper
• Anti‐inflammatory effects of PJ34, a poly(ADP‐ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice

  2006cites this paper
• Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation.

  2006cites this paper